Skip to main content
. 2015 Oct 2;1(9):e1500415. doi: 10.1126/sciadv.1500415

Fig. 1. Mono-7D6-Fab binds T cells without interrupting pMHC:TCR interactions and is functionally inert.

Fig. 1

(A) Mono-7D6-Fab binds to T cells. Thy1.2+CD4+ or Thy1.2+CD8+ B6 cells were analyzed for binding irrelevant Ms IgG, Mono-7D6-Fab, or 7D6 mAb detected by anti–Ms IgG fluorescein isothiocyanate. (B and C) Mono-7D6-Fab does not block antigen binding to transgenic TCRs. (B) Pmel-1 TCR transgenic cells were preincubated with control Ms IgG Fab or Mono-7D6-Fab, and Thy1.1+CD8+ cells were analyzed for binding H-2KD/hgp100 tetramer. (C) OT-I TCR transgenic cells were preincubated with control Ms IgG Fab or Mono-7D6-Fab, and Thy1.2+CD8+ cells were analyzed for binding H-2KB-OVA tetramer. (D and E) Mono-7D6-Fab does not alter T cell response to stimulation of transgenic TCRs by strong pMHC ligands. (D) Pmel-1 cells were cultured with no peptide or hgp100 peptide (500 ng/ml) in the presence of control Ms IgG or Mono-7D6-Fab and analyzed at 24 hours for Pmel-1 Vβ13 TCR down-regulation. (E) OT-I T cells were cultured with no peptide or 0.2 nM pOVA in the presence of control Ms IgG or Mono-7D6-Fab and analyzed at 24 hours for OT-I Vα2 TCR down-regulation. (F) Mono-7D6-Fab binding does not stimulate T cells. B6 cells were incubated with Ms IgG Fab, Mono-7D6-Fab, or 2C11 mAb and analyzed for induction of CD69 or CD25 expression. From (A) to (F), one representative experiment out of three or more performed experiments is shown.